Notably, the inhibition of ROS partially attenuated anxiety-like behaviors and hippocampal alterations induced by p21-OE, as well as phenotypes induced by CORT, highlighting the potential of targeting ROS or p21 in the hippocampus as a therapeutic approach to mitigate mood disorders induced by chronic stress. This evidence concerns the gene CDKN1A and mood disorder.